Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Tamoxifen and flaxseed alter angiogenesis regulators in normal human breast tissue in vivo.

Åberg UW, Saarinen N, Abrahamsson A, Nurmi T, Engblom S, Dabrosin C.

PLoS One. 2011;6(9):e25720. doi: 10.1371/journal.pone.0025720. Epub 2011 Sep 30.

2.

Estradiol, tamoxifen, and flaxseed alter IL-1β and IL-1Ra levels in normal human breast tissue in vivo.

Abrahamsson A, Morad V, Saarinen NM, Dabrosin C.

J Clin Endocrinol Metab. 2012 Nov;97(11):E2044-54. doi: 10.1210/jc.2012-2288. Epub 2012 Aug 28.

PMID:
22930784
4.

In vivo measurement of tumor estradiol and vascular endothelial growth factor in breast cancer patients.

Garvin S, Dabrosin C.

BMC Cancer. 2008 Mar 18;8:73. doi: 10.1186/1471-2407-8-73.

5.
6.

Tamoxifen and aromatase inhibitors differentially affect vascular endothelial growth factor and endostatin levels in women with breast cancer.

Holmes CE, Huang JC, Pace TR, Howard AB, Muss HB.

Clin Cancer Res. 2008 May 15;14(10):3070-6. doi: 10.1158/1078-0432.CCR-07-4640.

7.

Tamoxifen, flaxseed, and the lignan enterolactone increase stroma- and cancer cell-derived IL-1Ra and decrease tumor angiogenesis in estrogen-dependent breast cancer.

Lindahl G, Saarinen N, Abrahamsson A, Dabrosin C.

Cancer Res. 2011 Jan 1;71(1):51-60. doi: 10.1158/0008-5472.CAN-10-2289. Epub 2010 Nov 19.

8.
9.

Angiogenin regulation by estradiol in breast tissue: tamoxifen inhibits angiogenin nuclear translocation and antiangiogenin therapy reduces breast cancer growth in vivo.

Nilsson UW, Abrahamsson A, Dabrosin C.

Clin Cancer Res. 2010 Jul 15;16(14):3659-69. doi: 10.1158/1078-0432.CCR-10-0501. Epub 2010 May 25.

11.
12.

Gene transfer of matrix metalloproteinase-9 induces tumor regression of breast cancer in vivo.

Bendrik C, Robertson J, Gauldie J, Dabrosin C.

Cancer Res. 2008 May 1;68(9):3405-12. doi: 10.1158/0008-5472.CAN-08-0295.

13.

Estradiol increases VEGF in human breast studied by whole-tissue culture.

Garvin S, Nilsson UW, Huss FR, Kratz G, Dabrosin C.

Cell Tissue Res. 2006 Aug;325(2):245-51. Epub 2006 Mar 28.

PMID:
16568303
14.

Adipokines and Vascular Endothelial Growth Factor in Normal Human Breast Tissue in Vivo - Correlations and Attenuation by Dietary Flaxseed.

Morad V, Abrahamsson A, Kjölhede P, Dabrosin C.

J Mammary Gland Biol Neoplasia. 2016 Apr 8. [Epub ahead of print]

PMID:
27059487
15.
16.

Estradiol affects extracellular leptin:adiponectin ratio in human breast tissue in vivo.

Morad V, Abrahamsson A, Dabrosin C.

J Clin Endocrinol Metab. 2014 Sep;99(9):3460-7. doi: 10.1210/jc.2014-1129. Epub 2014 May 5. Erratum in: J Clin Endocrinol Metab. 2014 Sep;99(9):3468.

PMID:
24796929
17.
18.

Increased endostatin generation and decreased angiogenesis via MMP-9 by tamoxifen in hormone dependent ovarian cancer.

Bendrik C, Karlsson L, Dabrosin C.

Cancer Lett. 2010 Jun 1;292(1):32-40. doi: 10.1016/j.canlet.2009.11.002. Epub 2009 Nov 26.

PMID:
19944523
19.

Tamoxifen decreases extracellular TGF-beta1 secreted from breast cancer cells--a post-translational regulation involving matrix metalloproteinase activity.

Nilsson UW, Jönsson JA, Dabrosin C.

Exp Cell Res. 2009 Jan 1;315(1):1-9. doi: 10.1016/j.yexcr.2008.10.015. Epub 2008 Oct 28.

PMID:
18996114
20.

MMP-2 and MMP-9 activity is regulated by estradiol and tamoxifen in cultured human breast cancer cells.

Nilsson UW, Garvin S, Dabrosin C.

Breast Cancer Res Treat. 2007 May;102(3):253-61. Epub 2006 Oct 10.

PMID:
17031577
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk